Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Myovant Sciences Ltd. MYOV

Full chart Compare
Set alert

Price alert · MYOV

All alert types
26.98 +26.98

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

-2.96 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -6.0×
FY 2016: 0.0×FY 2017: -6.9×FY 2018: -8.8×FY 2019: -5.8×FY 2020: -2.2×FY 2021: -7.3×FY 2022: -6.0×
FY 2016 5y median -6.0× FY 2022
P/S 5.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 31.2×FY 2022: 5.4×
FY 2016 5y median 0.0× FY 2022
P/B -2.6×
FY 2016: 0.0×FY 2017: 3.5×FY 2018: 33.6×FY 2019: 367×FY 2020: -6.0×FY 2021: -5.2×FY 2022: -2.6×
FY 2016 5y median -2.6× FY 2022
P/FCF -4.6×
FY 2016: 0.0×FY 2017: -30.1×FY 2018: -10.7×FY 2019: -7.1×FY 2020: -2.9×FY 2021: 5.0×FY 2022: -4.6×
FY 2016 5y median -4.6× FY 2022
EV/EBITDA -6.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -8.5×FY 2019: -6.0×FY 2020: -2.5×FY 2021: -6.4×FY 2022: -6.5×
FY 2016 5y median -6.4× FY 2022
EV/Sales 5.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 26.1×FY 2022: 5.2×
FY 2016 5y median 0.0× FY 2022
FCF Yield -21.8%
FY 2016: 0.0%FY 2017: -3.3%FY 2018: -9.3%FY 2019: -14.2%FY 2020: -34.3%FY 2021: 19.9%FY 2022: -21.8%
FY 2016 5y median -14.2% FY 2022

Profitability

Gross Margin 77.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 96.7%FY 2022: 77.7%
FY 2016 5y median 0.0% FY 2022
Operating Margin -81.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -439.6%FY 2022: -81.1%
FY 2016 5y median 0.0% FY 2022
Net Margin -89.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -430.1%FY 2022: -89.2%
FY 2016 5y median 0.0% FY 2022
ROE 43.5%
FY 2016: 0.0%FY 2017: -50.0%FY 2018: -379.7%FY 2019: -6311.7%FY 2020: 266.9%FY 2021: 72.1%FY 2022: 43.5%
FY 2016 5y median 43.5% FY 2022
ROIC -68.9%
FY 2016: 0.0%FY 2017: -33.4%FY 2018: -172.0%FY 2019: -247.2%FY 2020: -1258.1%FY 2021: -58.5%FY 2022: -68.9%
FY 2016 5y median -172.0% FY 2022
ROA -39.6%
FY 2016: 0.0%FY 2017: -45.0%FY 2018: -120.3%FY 2019: -158.1%FY 2020: -272.8%FY 2021: -35.2%FY 2022: -39.6%
FY 2016 5y median -120.3% FY 2022

Growth (YoY)

Revenue 289.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 289.4%
FY 2016 FY 2022
Operating Income 28.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -152.5%FY 2019: -87.7%FY 2020: -2.2%FY 2021: 3.7%FY 2022: 28.2%
FY 2016 FY 2022
EPS (diluted) 21.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -41.8%FY 2019: -69.7%FY 2020: 17.6%FY 2021: 16.0%FY 2022: 21.6%
FY 2016 FY 2022
Free Cash Flow -173.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -514.4%FY 2019: -91.2%FY 2020: 1.4%FY 2021: 265.9%FY 2022: -173.1%
FY 2016 FY 2022

Financial Health

Current Ratio 2.0×
FY 2016: 0.0×FY 2017: 10.0×FY 2018: 3.1×FY 2019: 2.3×FY 2020: 1.0×FY 2021: 2.5×FY 2022: 2.0×
FY 2016 5y median 2.3× FY 2022
Quick Ratio 1.9×
FY 2016: 0.0×FY 2017: 10.0×FY 2018: 3.1×FY 2019: 2.3×FY 2020: 1.0×FY 2021: 2.5×FY 2022: 1.9×
FY 2016 5y median 2.3× FY 2022
Debt / Equity -0.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 1.2×FY 2019: 22.9×FY 2020: -1.2×FY 2021: -1.0×FY 2022: -0.8×
FY 2016 5y median -0.8× FY 2022
Net Debt / EBITDA 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.5×FY 2019: 0.2×FY 2020: -0.2×FY 2021: 1.3×FY 2022: 0.2×
FY 2016 5y median 0.2× FY 2022
Interest Coverage -13.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -68.9×FY 2019: -30.0×FY 2020: -21.4×FY 2021: -25.1×FY 2022: -13.4×
FY 2016 5y median -25.1× FY 2022

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-03-31